RECURRENT PROSTATE CANCER
Clinical trials for RECURRENT PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new RECURRENT PROSTATE CANCER trials appear
Sign up with your email to follow new studies for RECURRENT PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental DNA vaccine aims to train immune system against prostate cancer
⭐️ VACCINE ⭐️ Recruiting nowThis early-phase trial tests whether an experimental DNA vaccine (pTVG-HP) combined with the immunotherapy drug nivolumab and targeted radiation can help the immune system attack prostate cancer that has returned in a few spots. The study involves 14 men whose cancer has come bac…
Matched conditions: RECURRENT PROSTATE CANCER
Phase: PHASE1 • Sponsor: University of Wisconsin, Madison • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 00:31 UTC
-
New trial aims to Fine-Tune prostate cancer treatment timing
Disease control Recruiting nowThis study looks at the best timing for combining targeted radiation (SBRT) with hormone therapy in men whose prostate cancer has returned and spread. It also tests if radiation to the pelvis can stop cancer from spreading further. About 532 men with recurrent, hormone-sensitive …
Matched conditions: RECURRENT PROSTATE CANCER
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 17, 2026 00:43 UTC
-
New hope for recurrent prostate cancer: drug combo aims to delay PSA rise without hormones
Disease control Recruiting nowThis study tests whether adding an injected drug (PDS01ADC) to a daily pill (enzalutamide) can better control prostate cancer that has returned after initial treatment. About 65 men with rising PSA and positive PET scans will be enrolled. The goal is to see if the combination kee…
Matched conditions: RECURRENT PROSTATE CANCER
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Could a common antifungal pill slow prostate Cancer's return?
Disease control Recruiting nowThis study tests whether terbinafine, a widely used antifungal medication, can slow the rise of PSA levels in men whose prostate cancer has returned after initial treatment. About 42 men with biochemical recurrence but no visible tumors on scans will take oral terbinafine for 12 …
Matched conditions: RECURRENT PROSTATE CANCER
Phase: PHASE2 • Sponsor: Swiss Cancer Institute • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New laser therapy targets recurrent prostate cancer without surgery
Disease control Recruiting nowThis study tests a treatment for men whose prostate cancer has come back after radiation. It uses a special drug (verteporfin) that is activated by lasers placed directly into the tumor. The goal is to safely destroy the cancer while avoiding major side effects. About 66 men will…
Matched conditions: RECURRENT PROSTATE CANCER
Phase: PHASE1, PHASE2 • Sponsor: SpectraCure AB • Aim: Disease control
Last updated May 12, 2026 13:43 UTC
-
Veterans trial aims to delay prostate cancer progression with PET-Guided precision
Disease control Recruiting nowThis study compares standard systemic therapy alone versus standard therapy plus PET-directed local therapy in 464 veterans with prostate cancer that has returned in a few spots (oligorecurrence). The goal is to see if adding targeted local treatment can delay the cancer from bec…
Matched conditions: RECURRENT PROSTATE CANCER
Phase: PHASE2, PHASE3 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated May 11, 2026 20:53 UTC
-
Second radiation blasts recurrent prostate cancer in new trial
Disease control Recruiting nowThis study tests a precise, high-dose radiation treatment (brachytherapy) for men whose prostate cancer has returned after previous radiation. About 30 participants will receive this salvage therapy to control the cancer while limiting side effects. The goal is to improve outcome…
Matched conditions: RECURRENT PROSTATE CANCER
Phase: NA • Sponsor: British Columbia Cancer Agency • Aim: Disease control
Last updated Apr 28, 2026 13:02 UTC
-
New scan could catch prostate cancer spread earlier in High-Risk patients
Knowledge-focused Recruiting nowThis study looks at whether a special type of PET scan (PSMA-PET) can find early signs of prostate cancer that has spread to other parts of the body. It involves 60 men who had a high genetic risk score from a previous study. The goal is to see how well the genetic test matches w…
Matched conditions: RECURRENT PROSTATE CANCER
Phase: PHASE2, PHASE3 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Knowledge-focused
Last updated May 17, 2026 00:30 UTC